SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Shasun spurts on raising Rs 1,102 crore via QIP

23 Dec 2015 Evaluate

Strides Shasun is currently trading at Rs 1301.50, up by 3.15 points or 0.24% from its previous closing of Rs. 1298.35 on the BSE.

The scrip opened at Rs. 1304.60 and has touched a high and low of Rs. 1310.00 and Rs. 1287.70 respectively. So far 14435 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1412.45 on 23-Nov-2015 and a 52 week low of Rs. 822.20 on 10-Feb-2015.

Last one week high and low of the scrip stood at Rs. 1332.00 and Rs. 1255.05 respectively. The current market cap of the company is Rs. 10498.91 crore.

The promoters holding in the company stood at 27.65% while Institutions and Non-Institutions held 44.42% and 27.94% respectively.

Strides Shasun has mopped up over Rs 1,102 crore through qualified institutional placement (QIP), which was opened on December 17. The QIP Committee of the company, on December 21, 2015, approved closure of issue period of the QIP . The issue price is at a discount of 4.97 per cent to the floor price of Rs 1,344.78 per equity share, in accordance with proviso to Regulation 85(1) of SEBI ICDR regulations.

Strides Shasun is a vertically integrated global pharmaceutical company headquartered in Bangalore. The company has four business verticals - Regulated Markets, Emerging Markets, Institutional Business and Pharmaceutical Services & Active Ingredients.

Strides Pharma Scien Share Price

1000.70 6.80 (0.68%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×